ZYKADIA 150 mg/1

ZYKADIA 150 mg is a medication used to treat certain types of cancer. This film-coated tablet contains ceritinib, a targeted therapy designed for oral administration. Learn more about its uses and effects.

ZYKADIA 150 mg is primarily used in the treatment of specific types of cancer. It works by targeting certain proteins involved in cancer cell growth. Patients often wonder, 'What is ZYKADIA used for?' This medication is typically prescribed for advanced stages of cancer, aiming to slow down the progression of the disease.

Common effects of ZYKADIA 150 mg may include gastrointestinal issues such as nausea and diarrhea. Some patients also report fatigue and changes in appetite. These effects can vary widely among individuals, and it's important to monitor how the body responds to the medication.

ZYKADIA 150 mg should be handled with care. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should be aware of potential side effects and discuss any concerns with their doctor.

ZYKADIA 150 mg may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how this medication works.